NASDAQ Companies

BROOMFIELD, Colo., Feb. 20, 2024 (GLOBE NEWSWIRE) — Noodles & Company (NASDAQ: NDLS) today announced that it will host a […]

Signed 8 deals in the fourth quarter and 32 in 2023 across both media and semiconductor Paid down $29 million […]

CHICAGO, Feb. 20, 2024 (GLOBE NEWSWIRE) — Potbelly Corporation (NASDAQ: PBPB) (“Potbelly” or the “Company”), the iconic neighborhood sandwich shop […]

NEWARK, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing […]

BRISBANE, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class […]

DURHAM, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), […]

MONTCLAIR, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) — 180 Degree Capital Corp. (NASDAQ:TURN) (“180 Degree Capital” and the “Company”), today […]

HOUSTON, Feb. 20, 2024 (GLOBE NEWSWIRE) — Skyward Specialty Insurance Group, Inc.TM (Nasdaq: SKWD) (“Skyward Specialty” or the “Company”) today […]

PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market PHAXIAM remains listed on Euronext […]

SOUTH SAN FRANCISCO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today […]